Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Find out which credit cards have the best rewards to maximize your benefits. Make an informed choice for your spending habits.
27,830 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Amazon’s cloud powerhouse AWS posted its strongest growth in more than three years, as AI infrastructure investments ...
Oracle delivered a dramatic rise in May as it pivots toward AI cloud infrastructure. This article breaks down the dri...
As WWDC 2026 opens, Apple faces a pivotal moment: Tim Cook's leadership transition and a bold AI strategy that could ...
Oracle is set to report its June quarter as AI demand tests the cloud backbone. Backlog and RPO could reveal real app...
Netflix has staged a comeback that rewards patient investors, but the last year also exposed two distinct paths for t...
Tensions abroad sparked fears of a jet fuel shortage, but industry data and regulators say the fuel crisis never exis...
A storied dividend king trades at a discount as Wall Street shifts away. Here’s why patient investors are doubling do...
Rocket Lab faces a watershed moment as it logs another quarter of rising revenue and a multi-billion backlog while we...
Ethereum trades around $2,000 as a decisive move looms. This report examines the price action, key levels, and what i...
Eric Trump’s American Bitcoin announced a 1-for-15 reverse stock split to protect its Nasdaq listing as its treasury ...
Cameco stock sliding below $120 has investors weighing risk and opportunity. This guide breaks down the uranium outlo...